Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2e)-3-(5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl))-2-nonyl-2-propenoic Acid
2. E 3330
3. E-3330
4. E3330
1. E3330
2. 136164-66-4
3. E-3330
4. E 3330
5. Apx3330
6. Chembl578390
7. Apx 3330
8. 11267ui968
9. (e)-2-((4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylene)undecanoic Acid
10. Apx-3330
11. (2e)-3-(5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl))-2-nonyl-2-propenoic Acid
12. Schembl3758716
13. Schembl3758719
14. Dtxsid201121926
15. Hms3886n15
16. Unii-11267ui968
17. Ex-a2212
18. Bdbm50303955
19. S7445
20. Zinc14252145
21. Ccg-268389
22. (2e)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid
23. Hy-19357
24. Cs-0015424
25. E3330, >=98% (hplc)
26. Ape1/ref-1 Redox Inhibitor Apx3330
27. A14440
28. A911827
29. (e)-3-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dienyl)-2-nonylpropenoic Acid
30. (e)-3-(5,6-dimethoxy-3-methyl-14-dioxocyclohexa-25-dienyl)-2-nonylpropenoic Acid
31. (2e)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]undecanoic Acid
32. Undecanoic Acid, 2-((4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene)-, (2e)-
33. Undecanoic Acid, 2-((4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene)-, (e)-
| Molecular Weight | 378.5 g/mol |
|---|---|
| Molecular Formula | C21H30O6 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 12 |
| Exact Mass | 378.20423867 g/mol |
| Monoisotopic Mass | 378.20423867 g/mol |
| Topological Polar Surface Area | 89.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 666 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A APX3330 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of APX3330, including repackagers and relabelers. The FDA regulates APX3330 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. APX3330 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A APX3330 supplier is an individual or a company that provides APX3330 active pharmaceutical ingredient (API) or APX3330 finished formulations upon request. The APX3330 suppliers may include APX3330 API manufacturers, exporters, distributors and traders.
APX3330 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of APX3330 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right APX3330 GMP manufacturer or APX3330 GMP API supplier for your needs.
A APX3330 CoA (Certificate of Analysis) is a formal document that attests to APX3330's compliance with APX3330 specifications and serves as a tool for batch-level quality control.
APX3330 CoA mostly includes findings from lab analyses of a specific batch. For each APX3330 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
APX3330 may be tested according to a variety of international standards, such as European Pharmacopoeia (APX3330 EP), APX3330 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (APX3330 USP).
LOOKING FOR A SUPPLIER?
